ABIOMED Inc. (ABMD)

319.78
NASDAQ : Health Technology
Prev Close 320.78
Day Low/High 315.38 / 332.15
52 Wk Low/High 186.72 / 459.75
Avg Volume 656.10K
Exchange NASDAQ
Shares Outstanding 45.04M
Market Cap 14.45B
EPS 2.50
P/E Ratio 77.67
Div & Yield N.A. (N.A)

Latest News

Express Scripts, Lockheed Martin: 'Mad Money' Lightning Round

Express Scripts, Lockheed Martin: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Express Scripts, Lockheed Martin, Raytheon, Abiomed.

Abiomed Is Set for Big Gains Once It Breaks Out Above $460

Abiomed Is Set for Big Gains Once It Breaks Out Above $460

Let's check out the charts and indicators.

Another Day of Rotation, but of a Different Sort

Another Day of Rotation, but of a Different Sort

Big-cap FAANG names and Apple, in particular, were the beneficiaries.

Children's Place, Abiomed, Barrick Gold: 'Mad Money' Lightning Round

Children's Place, Abiomed, Barrick Gold: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Children's Place, Abiomed, Barrick Gold, Dynavax Technologies, Zebra Technologies, Chesapeake Energy.

Be Alert For Buying Opportunities: Cramer's 'Mad Money' Recap (Monday 7/16/18)

Be Alert For Buying Opportunities: Cramer's 'Mad Money' Recap (Monday 7/16/18)

Jim Cramer says this market is all about being opportunistic, about being willing to fight the tide.

10 Stocks That Investors Have Plowed Into This Year With Reckless Abandon

10 Stocks That Investors Have Plowed Into This Year With Reckless Abandon

Investors have fallen in love with 10 stocks this year despite their heady valuations. Talk about dangerous.

Automatic Data Processing, ADT, Abiomed: 'Mad Money' Lightning Round

Automatic Data Processing, ADT, Abiomed: 'Mad Money' Lightning Round

Jim Cramer weighs in on Automatic Data Processing, ADT, Discovery Communications, Abiomed, L Brands and more.

Stocks Defying Gravity: Cramer's 'Mad Money' Recap (Monday 6/11/18)

Stocks Defying Gravity: Cramer's 'Mad Money' Recap (Monday 6/11/18)

Markets look calm, but we're seeing some extraordinary breakouts, says Jim Cramer.

FANG Stocks Only Outperform in Odd Years: Here Are 18 Alternative Picks for 2018

FANG Stocks Only Outperform in Odd Years: Here Are 18 Alternative Picks for 2018

For the past 11 years, FANG stocks have outperformed in years that end in an odd number and underperformed in years that end with an even number. That's not good news moving into 2018.

Closing the Door on Abiomed

Closing the Door on Abiomed

It's good as a long-term name, but as an options trade, it's time to go.

Capturing Profits on AIG

Capturing Profits on AIG

Let's roll with the sure thing and not wait for expiry.

TheStreet Quant Rating: B- (Buy)